









Markets
/
Stocks
/
nasdaq-lh
/

Labcorp Holdings Inc

269.810USD

+1.770+0.66%

Close 01/29, 16:00（ET）Quotes delayed by 15 min

22.39BMarket Cap

26.32P/E TTM



Labcorp Holdings Inc

269.810

+1.770+0.66%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Labcorp Holdings Inc

Currency: USD Updated: 2026-01-29

Key Insights

Labcorp Holdings Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 3 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 300.09.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Labcorp Holdings Inc's Score

Industry at a Glance

Industry Ranking

3 / 75

Overall Ranking

41 / 4540

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative-

Labcorp Holdings Inc Highlights

StrengthsRisks

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 32.56%.

Fairly Valued

The company’s latest PE is 26.32, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 80.86M shares, decreasing 5.34% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 94.00 shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.29.

Analyst Rating

Based on 21 analysts

Buy

Current Rating

300.086

Target Price

+10.68%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-01-29

The current financial score of Labcorp Holdings Inc is 8.81, ranking 15 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 3.56B, representing a year-over-year increase of 8.58%, while its net profit experienced a year-over-year increase of 54.22%.

Score

Industry at a Glance

Previous score

8.81

Change



Financials

6.72

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.68

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.11

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.55

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Labcorp Holdings Inc's Company Valuation

Currency: USD Updated: 2026-01-29

The current valuation score of Labcorp Holdings Inc is 5.66, ranking 69 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 26.32, which is 84.14% below the recent high of 48.46 and 50.40% above the recent low of 13.05.

Score

Industry at a Glance

Previous score

5.66

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 3/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-01-29

The current earnings forecast score of Labcorp Holdings Inc is 8.19, ranking 24 out of 75 in the Healthcare Providers & Services industry. The average price target is 304.00, with a high of 342.00 and a low of 260.00.

Score

Industry at a Glance

Previous score

8.19

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 21 analysts

Buy

Current Rating

300.086

Target Price

+10.68%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Labcorp Holdings Inc

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-01-29

The current price momentum score of Labcorp Holdings Inc is 9.34, ranking 2 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 281.79 and the support level at 251.42, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.20

Change

0.14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

1.947

Buy

RSI(14)

59.551

Neutral

STOCH(KDJ)(9,3,3)

54.269

Sell

ATR(14)

5.869

High Vlolatility

CCI(14)

45.522

Neutral

Williams %R

20.464

Buy

TRIX(12,20)

0.216

Sell

StochRSI(14)

40.005

Neutral

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

268.602

Buy

MA10

269.319

Buy

MA20

261.794

Buy

MA50

260.980

Buy

MA100

267.133

Buy

MA200

260.938

Buy

Institutional Confidence

Currency: USD Updated: 2026-01-29

The current institutional shareholding score of Labcorp Holdings Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 97.54%, representing a quarter-over-quarter decrease of 2.69%. The largest institutional shareholder is The Vanguard, holding a total of 9.78M shares, representing 11.79% of shares outstanding, with 1.89% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

9.78M

-0.68%

BlackRock Institutional Trust Company, N.A.

4.39M

-0.24%

State Street Investment Management (US)

3.83M

-0.81%

Victory Capital Management Inc.

2.64M

+20.04%

Allspring Global Investments, LLC

2.00M

-0.23%

Geode Capital Management, L.L.C.

2.12M

+0.46%

Wellington Management Company, LLP

2.11M

+15.91%

Select Equity Group, L.P.

1.84M

-13.87%

Diamond Hill Capital Management Inc.

Star Investors

1.64M

-9.94%

Dimensional Fund Advisors, L.P.

1.25M

-3.23%

Risk Assessment

Currency: USD Updated: 2026-01-29

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Labcorp Holdings Inc is 8.79, ranking 4 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.02. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Labcorp Holdings Inc’s latest ESG disclosure leads the Healthcare Providers & Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.